|
|
Volumn 45, Issue 4, 2009, Pages 251-254
|
|
Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients
a
|
|
Author keywords
Body mass index; Insomnia; Psychiatry; Quetiapine; Weight gain
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
ARIPIPRAZOLE;
GABAPENTIN;
HYPNOTIC AGENT;
MOOD STABILIZER;
OLANZAPINE;
PAROXETINE;
QUETIAPINE;
RISPERIDONE;
TRAZODONE;
VALPROIC ACID;
ZIPRASIDONE;
ADD ON THERAPY;
ADULT;
AGED;
ARTICLE;
BEDTIME DOSAGE;
BODY MASS;
CAUCASIAN;
CLINICAL ARTICLE;
COMMUNITY MENTAL HEALTH CENTER;
CONTROLLED STUDY;
DRUG USE;
FEMALE;
HUMAN;
INSOMNIA;
LOW DRUG DOSE;
MALE;
MEDICAL RECORD REVIEW;
MENTAL PATIENT;
PRESCRIPTION;
PSYCHIATRIC DIAGNOSIS;
RETROSPECTIVE STUDY;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
TREATMENT INDICATION;
WAIST CIRCUMFERENCE;
WEIGHT;
WEIGHT CHANGE;
ADULT;
ALABAMA;
ANTIPSYCHOTIC AGENTS;
BODY MASS INDEX;
COMORBIDITY;
DIBENZOTHIAZEPINES;
FEMALE;
HUMANS;
MALE;
MEDICAL AUDIT;
MENTAL DISORDERS;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
SLEEP INITIATION AND MAINTENANCE DISORDERS;
WEIGHT GAIN;
YOUNG ADULT;
|
|
EID: 68649100415
PISSN: 00103853
EISSN: None
Source Type: Journal
DOI: 10.1007/s10597-009-9200-0 Document Type: Article |
|
Times cited : (54)
|
|
References (12)
|
